ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Stakeholder priorities for advancing integrative oncology across a pluralistic health system: a qualitative study from Singapore.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Singapore, more than half of patients with cancer use traditional or complementary therapies after diagnosis. Such use is often self-directed and undisclosed to oncology clinicians, creating safety risks and care coordination challenges. To support evidence-informed integration of such therapies within conventional cancer care, this study explored stakeholder priorities for advancing integrative oncology (IO) in Singapore's pluralistic health system.
methodsWe conducted a multi-stakeholder roundtable at the National Cancer Centre Singapore. Twenty-two participants were purposively recruited across oncology, palliative care, nursing, pharmacy, allied health, Traditional Chinese Medicine, research, and service coordination. The session was audio-recorded, transcribed verbatim, and analyzed using reflexive thematic analysis.
resultsFive themes were identified. First, participants prioritized earlier, recurring discussions about IO therapies across the cancer care trajectory. Second, bridging conventional and traditional medicine required practical infrastructure, including shared documentation and bidirectional referral pathways, allowing patients to be escalated from community to specialists. Third, IO-related decisions were often shaped by family members and community networks, underscoring the need to accommodate relational decision-making when supporting patient autonomy. Fourth, cost and perceived clinical legitimacy shaped access, as patients were less likely to pay out-of-pocket without oncology endorsement. Lastly, cancer centers were viewed as instrumental in providing clinical credibility and workforce training on evidence-informed IO therapies.
conclusionsIn pluralistic health systems where traditional care use is culturally embedded, advancing IO should prioritize making pre-existing therapy use safer, more visible, and better coordinated. Real-world outcomes data on IO uptake in conventional care are needed to inform future subsidy mechanisms.
Indexed as
Identifiers
42706442What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.